Gumen, Joan A.

HRN: 17-17-40  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/26/2022
CEFUROXIME 500MG (TAB)
05/26/2022
06/01/2022
PO
500mg
BID X 7 Days
Pus Cells: 4-10; WBC: 13.1
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: